Business

January 21, 2014 11:52 AM

Durham's Argos Therapeutics looking to raise up to $60 million with IPO

Argos Therapeutics is hoping that Wall Street will value its business in the neighborhood of $250 million. The Durham drug-development company provided more details Tuesday in its latest filing with the Securities and Exchange Commission.

Related content

Comments

Videos

More Videos

Two-year-old girl from Brazil sees her mother for the first time thanks to surgery 02:34

Two-year-old girl from Brazil sees her mother for the first time thanks to surgery

Inside Counter Culture Coffee's new headquarters 01:41

Inside Counter Culture Coffee's new headquarters

HB2 fallout impacts High Point Furniture Market 00:56

HB2 fallout impacts High Point Furniture Market

Sights & sounds of a Cuban tobacco harvest 01:04

Sights & sounds of a Cuban tobacco harvest

White House says Zika is worse than previously thought 02:09

White House says Zika is worse than previously thought

Blue Cross CEO and chief operating officer address employees at March meeting 01:37

Blue Cross CEO and chief operating officer address employees at March meeting

Apple announces product updates and new headquarters 01:23

Apple announces product updates and new headquarters

Phononic solid-state cooling tech in RTP 01:10

Phononic solid-state cooling tech in RTP

Implus a growing Durham NC business 01:24

Implus a growing Durham NC business

CEO Brad Wilson of Blue Cross Blue Shield 01:55

CEO Brad Wilson of Blue Cross Blue Shield

WalMart Express closing in Four Oaks,NC 00:55

WalMart Express closing in Four Oaks,NC

Zika virus could spread to all the Americas 00:33

Zika virus could spread to all the Americas

Share Video

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs